IgA pemphigus

Clinics in Dermatology

Volumn 29, Issue 4, 2011, Pages 437-442

  Tsuruta, Daisuke ^a,b   Ishii, Norito ^a   Hamada, Takahiro ^a   Ohyama, Bungo ^a   Fukuda, Shunpei ^a   Koga, Hiroshi ^a   Imamura, Kazuko ^a   Kobayashi, Hiromi ^b   Karashima, Tadashi ^a   Nakama, Takekuni ^a   Dainichi, Teruki ^a   Hashimoto, Takashi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; ETRETIN; IMMUNOGLOBULIN A; ISOTRETINOIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADRENAL INSUFFICIENCY; ARTICLE; CHRONIC INFLAMMATION; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG SAFETY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FRACTURE; HISTOPATHOLOGY; HUMAN; IGA PEMPHIGUS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPATHOLOGY; INCIDENCE; LABORATORY TEST; NEOPLASM; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; STOMACH ULCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DESMOCOLLINS; DESMOSOMES; FEMALE; HUMANS; IMMUNOGLOBULIN A; INCIDENCE; INFANT; MALE; MIDDLE AGED; NEUTROPHILS; PEMPHIGUS; PREVALENCE; YOUNG ADULT;

EID: 79958803152     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.01.014     Document Type: Article

References (40)

1. Patricio P., Ferreira C., Gomes M.M., et al. Autoimmune bullous dermatoses: a review. Ann N Y Acad Sci 2009, 1173:203-210.
2. Hashimoto T. Recent advances in the study of the pathophysiology of pemphigus. Arch Dermatol Res 2003, 295:S2-11.
3. Hashimoto T. Immunopathology of IgA pemphigus. Clin Dermatol 2001, 19:683-689.
4. Hodak E., David M., Ingber A., et al. The clinical and histopathological spectrum of IgA-pemphigus-report of two cases. Clin Exp Dermatol 1990, 15:433-437.
5. Hashimoto T., Ebihara T., Nishikawa T. Studies of autoantigens recognized by IgA anti-keratinocyte cell surface antibodies. J Dermatol Sci 1996, 12:10-17.
6. Wallach D. Intraepidermal IgA pustulosis. J Am Acad Dermatol 1992, 27:993-1000.
7. Gengoux P., Tennstedt D., Lachapelle J.M. Intraepidermal neutrophilic IgA dermatosis: pemphigus-like IgA deposits. Dermatology 1992, 185:311-313.
8. Teraki Y., Amagai N., Hashimoto T., et al. Intercellular IgA dermatosis of childhood. Selective deposition of monomer IgA1 in the intercellular space of the epidermis. Arch Dermatol 1991, 127:221-224.
9. Hashimoto T., Ebihara T., Dmochowski M., et al. IgA antikeratinocyte surface autoantibodies from two types of intercellular IgA vesiculopustular dermatosis recognize distinct isoforms of desmocollin. Arch Dermatol Res 1996, 288:447-452.
10. Chorzelski T.P., Beutner E.H., Kowalewski C., et al. IgA pemphigus foliaceus with a clinical presentation of pemphigus herpetiformis. J Am Acad Dermatol 1991, 24:839-844.
11. Hashimoto T., Yasumoto S., Nagata Y., et al. Clinical, histopathological and immunological distinction in two cases of IgA pemphigus. Clin Exp Dermatol 2002, 27:636-640.
12. Hashimoto T., Kiyokawa C., Mori O., et al. Human desmocollin 1 (Dsc1. is an autoantigen for the subcorneal pustular dermatosis type of IgA pemphigus. J Invest Dermatol 1997, 109:127-131.
13. Amagai M., Komai A., Hashimoto T., et al. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 1999, 140:351-357.
14. Chan LS. Pemphigus, IgA. E-medicine. Available at:Accessed April 9, 2010. http://www.emedicine.medscape.com/article/1063776-overview.
15. Erdag G., Qureshi H.S., Greer K.E., et al. Immunoglobulin A pemphigus involving the perianal skin and oral mucosa: an unusual presentation. Cutis 2007, 80:218-220.
16. Kim S.C., Won J.H., Chung J., et al. IgA pemphigus: report of a case with immunoelectron localization of bound IgA in the skin. J Am Acad Dermatol 1996, 34:852-854.
17. Ishii N., Ishida-Yamamoto A., Hashimoto T. Immunolocalization of target autoantigens in IgA pemphigus. Clin Exp Dermatol 2004, 29:62-66.
18. Akiyama M., Hashimoto T., Sugiura M., et al. Ultrastructural localization of autoantigens of intercellular IgA vesiculopustular dermatosis in cultured human squamous cell carcinoma cells. Arch Dermatol Res 1992, 284:371-373.
19. Yasuda H., Kobayashi H., Hashimoto T., et al. Subcorneal pustular dermatosis type of IgA pemphigus: demonstration of autoantibodies to desmocollin-1 and clinical review. Br J Dermatol 2000, 143:144-148.
20. Karpati S., Amagai M., Liu W.L., et al. Identification of desmoglein 1 as autoantigen in a patient with intraepidermal neutrophilic IgA dermatosis type of IgA pemphigus. Exp Dermatol 2000, 9:224-228.
21. Hashimoto T., Komai A., Futei Y., et al. Detection of IgA autoantibodies to desmogleins by an enzyme-linked immunosorbent assay: the presence of new minor subtypes of IgA pemphigus. Arch Dermatol 2001, 137:735-738.
22. Endo Y., Tsujioka K., Tanioka M., et al. Bullous dermatosis associated with IgG antibodies specific for desmocollins. Eur J Dermatol 2010, 20:620-625.
23. Kopp T., Sitaru C., Pieczkowski F., et al. IgA pemphigus-occurrence of anti-desmocollin 1 and anti-desmoglein 1 antibody reactivity in an individual patient. J Dtsch Dermatol Ges 2006, 4:1045-1050.
24. Duker I., Schaller J., Rose C., et al. Subcorneal pustular dermatosis-type IgA pemphigus with autoantibodies to desmocollins 1, 2, and 3. Arch Dermatol 2009, 145:1159-1162.
25. Zaraa I., Kerkeni N., Sellami M., et al. IgG/IgA pemphigus with IgG and IgA antidesmoglein 3 antibodies and IgA antidesmoglein 1 antibodies detected by enzyme-linked immunosorbent assay: a case report and review of the literature. Int J Dermatol 2010, 49:298-302.
26. Fujihashi K., McGhee J.R., Kweon M.N., et al. gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses. J Exp Med 1996, 183:1929-1935.
27. Carayannopoulos L., Hexham J.M., Capra J.D. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1. J Exp Med 1996, 183:1579-1586.
28. Chan L.S., Vanderlugt C.J., Hashimoto T., et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 1998, 110:103-109.
29. Muller R., Heber B., Hashimoto T., et al. Autoantibodies against desmocollins in European patients with pemphigus. Clin Exp Dermatol 2009, 34:898-903.
30. Petropoulou H., Politis G., Panagakis P., et al. Immunoglobulin A pemphigus associated with immunoglobulin A gammopathy and lung cancer. J Dermatol 2008, 35:341-345.
31. Bruckner A.L., Fitzpatrick J.E., Hashimoto T., et al. Atypical IgA/IgG pemphigus involving the skin, oral mucosa, and colon in a child: a novel variant of IgA pemphigus?. Pediatr Dermatol 2005, 22:321-327.
32. Olney R.C. Mechanisms of impaired growth: effect of steroids on bone and cartilage. Horm Res 2009, 72:30-35.
33. Camisa C, Warner M. Treatment of pemphigus. Dermatol Nurs 1998;10:115-8, 23-31.
34. McLeish K.R., Miller F.N., Stelzer G.T., et al. Mechanism by which methylprednisolone inhibits acute immune complex-induced changes in vascular permeability. Inflammation 1986, 10:321-332.
35. Williams R.N., Paterson C.A. The influence of topical corticosteroid therapy upon polymorphonuclear leukocyte distribution, vascular integrity and ascorbate levels in endotoxin-induced inflammation of the rabbit eye. Exp Eye Res 1987, 44:191-198.
36. Zurier R.B., Weissman G. Anti-immunologic and anti-inflammatory effects of steroid therapy. Med Clin North Am 1973, 57:1295-1307.
37. Dequeker J. NSAIDs/corticosteroids-primum non nocere. Adv Exp Med Biol 1999, 455:319-325.
38. Gruss C., Zillikens D., Hashimoto T., et al. Rapid response of IgA pemphigus of subcorneal pustular dermatosis type to treatment with isotretinoin. J Am Acad Dermatol 2000, 43:923-926.
39. Ruiz-Genao D.P., Hernandez-Nunez A., Hashimoto T., et al. A case of IgA pemphigus successfully treated with acitretin. Br J Dermatol 2002, 147:1040-1042.
40. Howell S.M., Bessinger G.T., Altman C.E., et al. Rapid response of IgA pemphigus of the subcorneal pustular dermatosis subtype to treatment with adalimumab and mycophenolate mofetil. J Am Acad Dermatol 2005, 53:541-543.